At a glance
- Originator Kanegafuchi
- Class Anti-inflammatories; Antirheumatics; Furans; Lactones; Small molecules
- Mechanism of Action 5-lipoxygenase inhibitors; Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders